CN Stock MarketDetailed Quotes

300482 Guangzhou Wondfo Biotech

Watchlist
  • 28.77
  • -0.89-3.00%
Market Closed May 15 15:00 CST
13.58BMarket Cap27.04P/E (TTM)

Guangzhou Wondfo Biotech Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
3.54%861.09M
-51.33%2.76B
-57.32%2B
-63.09%1.49B
-68.32%831.63M
69.01%5.68B
87.32%4.7B
117.30%4.03B
276.87%2.63B
19.57%3.36B
Operating revenue
3.54%861.09M
-51.33%2.76B
-57.32%2B
-63.09%1.49B
-68.32%831.63M
69.01%5.68B
87.32%4.7B
117.30%4.03B
276.87%2.63B
19.57%3.36B
Other operating revenue
----
-24.25%5.22M
----
-41.70%3.85M
----
-3.11%6.89M
----
38.95%6.6M
----
22.23%7.11M
Total operating cost
0.28%609.78M
-47.01%2.29B
-51.44%1.62B
-57.58%1.15B
-59.46%608.06M
57.09%4.33B
75.23%3.33B
112.25%2.7B
182.13%1.5B
37.29%2.76B
Operating cost
0.54%290.15M
-62.22%1.03B
-65.58%744.9M
-69.04%542.55M
-69.54%288.59M
96.02%2.74B
151.46%2.16B
202.20%1.75B
361.11%947.56M
60.33%1.4B
Operating tax surcharges
48.62%3.04M
-31.63%12.17M
-47.30%5.63M
-50.56%4.23M
-42.78%2.04M
77.41%17.8M
58.25%10.69M
70.24%8.55M
34.24%3.57M
4.14%10.03M
Operating expense
9.45%159.81M
-30.08%649.99M
-30.87%465.93M
-43.47%315.5M
-58.21%146.02M
44.28%929.61M
24.42%673.97M
53.54%558.11M
101.00%349.41M
2.09%644.31M
Administration expense
-8.68%58.49M
-0.32%227.13M
-23.38%150.73M
-29.74%106.24M
-12.89%64.05M
-14.32%227.85M
5.56%196.72M
24.46%151.23M
16.88%73.53M
40.81%265.94M
Financial expense
-155.96%-7.25M
-817.68%-6.41M
60.48%-11.3M
-88.51%-13.39M
67.60%12.96M
-101.43%-697.96K
-209.34%-28.59M
-132.07%-7.1M
85.74%7.73M
74.90%48.92M
-Interest expense (Financial expense)
-10.42%7.14M
-7.99%29.93M
-4.81%21.49M
-0.04%14.71M
6.85%7.98M
17.21%32.53M
4.79%22.58M
3.27%14.71M
7.02%7.46M
149.21%27.76M
-Interest Income (Financial expense)
-108.50%-5.27M
-435.67%-27.61M
-265.23%-15.19M
-121.92%-9.03M
-224.51%-2.53M
-70.87%-5.15M
-150.37%-4.16M
-205.02%-4.07M
-13.94%-779.41K
64.78%-3.02M
Research and development
11.80%105.55M
-9.75%378M
-16.14%259.47M
-19.91%190.74M
-20.18%94.4M
7.09%418.84M
11.85%309.4M
31.82%238.15M
43.13%118.28M
39.96%391.09M
Credit Impairment Loss
-368.29%-8.46M
92.91%-1.5M
92.74%-885.39K
85.44%-1.62M
97.79%-1.81M
4.18%-21.14M
8.93%-12.2M
10.97%-11.1M
-1,027.87%-81.85M
-185.22%-22.06M
Asset Impairment Loss
----
85.41%-11.52M
----
----
----
-1,244.43%-78.97M
----
----
----
94.94%-5.87M
Other net revenue
-88.63%962.56K
357.37%78.88M
13.06%73.72M
27.21%45.45M
110.99%8.47M
-80.23%17.25M
-19.05%65.2M
-36.55%35.73M
-797.67%-77.04M
238.49%87.22M
Fair value change income
--867.58K
15.51%14.8M
281.58%14.23M
-98.04%289.84K
----
21.42%12.81M
--3.73M
--14.81M
----
4,351.73%10.55M
Invest income
81.08%2.96M
-47.97%31.1M
-23.74%26.48M
83.34%22.22M
-39.81%1.63M
25.92%59.77M
-27.69%34.72M
-60.16%12.12M
-69.12%2.71M
48.60%47.47M
-Including: Investment income associates
-669.69%-3M
-233.77%-4.33M
-2,264.09%-3.06M
73.99%-1.08M
66.39%-390.3K
156.38%3.24M
-96.20%141.57K
-248.87%-4.14M
-194.79%-1.16M
188.79%1.26M
Asset deal income
----
100.77%80.14K
-8,757.56%-55.22K
-4,937.69%-55.22K
---59.91K
-183,304.02%-10.4M
-99.68%637.85
-99.28%1.14K
----
-103.12%-5.67K
Other revenue
-35.62%5.6M
-16.77%45.92M
-12.83%33.95M
23.68%24.6M
315.37%8.7M
-3.45%55.17M
-14.82%38.95M
-47.91%19.89M
-77.98%2.1M
100.46%57.14M
Operating profit
8.72%252.27M
-59.85%549.14M
-67.76%462.77M
-71.63%388.22M
-77.86%232.04M
97.68%1.37B
108.18%1.44B
113.82%1.37B
495.71%1.05B
-6.51%691.9M
Add:Non operating Income
-65.58%228.83K
16.58%3.55M
126.48%2.12M
168.03%1.27M
10.43%664.73K
8.17%3.04M
-6.61%935.96K
-41.79%473.82K
39.19%601.92K
849.12%2.81M
Less:Non operating expense
-24.54%897.9K
90.81%11.92M
-11.85%5.4M
0.41%2.89M
31.16%1.19M
-56.07%6.25M
43.14%6.13M
4.51%2.88M
55.44%907.22K
50.41%14.22M
Total profit
8.68%251.6M
-60.37%540.76M
-67.87%459.49M
-71.70%386.6M
-77.91%231.51M
100.52%1.36B
108.42%1.43B
114.10%1.37B
496.05%1.05B
-6.90%680.49M
Less:Income tax cost
6.35%31.16M
-69.42%53.33M
-68.39%61.8M
-71.82%53.77M
-79.95%29.3M
264.04%174.41M
228.27%195.48M
138.34%190.8M
525.74%146.15M
-58.02%47.91M
Net profit
9.02%220.44M
-59.04%487.43M
-67.79%397.69M
-71.68%332.82M
-77.57%202.21M
88.14%1.19B
97.03%1.23B
110.62%1.18B
491.50%901.71M
2.56%632.58M
Net profit from continuing operation
9.02%220.44M
-58.74%491.01M
-67.79%397.69M
-71.68%332.82M
-77.57%202.21M
83.81%1.19B
97.03%1.23B
110.62%1.18B
491.50%901.71M
4.97%647.47M
Net income from discontinuing operating
----
---3.58M
----
----
----
----
----
----
----
---14.88M
Less:Minority Profit
243.94%2.11M
97.17%-196.42K
60.16%-2.12M
41.13%-1.68M
18.45%-1.47M
-274.78%-6.94M
-697.92%-5.33M
-227.87%-2.85M
39.63%-1.8M
89.33%-1.85M
Net profit of parent company owners
7.20%218.33M
-59.26%487.62M
-67.75%399.81M
-71.60%334.5M
-77.46%203.68M
88.68%1.2B
97.67%1.24B
111.98%1.18B
481.32%903.51M
0.04%634.43M
Earning per share
Basic earning per share
6.52%0.49
-59.41%1.1
-67.62%0.91
-71.54%0.76
-77.56%0.46
89.51%2.71
97.89%2.81
111.90%2.67
485.71%2.05
-0.69%1.43
Diluted earning per share
6.52%0.49
-59.41%1.1
-67.62%0.91
-71.54%0.76
-77.56%0.46
89.51%2.71
97.89%2.81
111.90%2.67
485.71%2.05
-0.69%1.43
Other composite income
5.66%413.48K
-151.84%-109.99M
-79.64%2.22M
-57.68%1.91M
-80.12%391.33K
-223.20%-43.67M
2,422.29%10.89M
789.91%4.52M
264.77%1.97M
73.16%35.45M
Other composite income of parent company owners
5.66%413.48K
-151.84%-109.99M
-79.64%2.22M
-57.68%1.91M
-80.12%391.33K
-223.20%-43.67M
2,422.29%10.89M
789.91%4.52M
264.77%1.97M
73.16%35.45M
Total composite income
9.01%220.86M
-67.08%377.44M
-67.89%399.9M
-71.62%334.74M
-77.58%202.6M
71.62%1.15B
98.92%1.25B
111.68%1.18B
490.70%903.68M
4.83%668.03M
Total composite income of parent company owners
7.19%218.75M
-67.26%377.64M
-67.86%402.03M
-71.55%336.42M
-77.46%204.07M
72.18%1.15B
99.56%1.25B
113.04%1.18B
480.57%905.48M
2.33%669.88M
Total composite income of minority owners
243.94%2.11M
97.17%-196.42K
60.16%-2.12M
41.13%-1.68M
18.45%-1.47M
-274.78%-6.94M
-697.92%-5.33M
-227.87%-2.85M
39.63%-1.8M
89.33%-1.85M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 3.54%861.09M-51.33%2.76B-57.32%2B-63.09%1.49B-68.32%831.63M69.01%5.68B87.32%4.7B117.30%4.03B276.87%2.63B19.57%3.36B
Operating revenue 3.54%861.09M-51.33%2.76B-57.32%2B-63.09%1.49B-68.32%831.63M69.01%5.68B87.32%4.7B117.30%4.03B276.87%2.63B19.57%3.36B
Other operating revenue -----24.25%5.22M-----41.70%3.85M-----3.11%6.89M----38.95%6.6M----22.23%7.11M
Total operating cost 0.28%609.78M-47.01%2.29B-51.44%1.62B-57.58%1.15B-59.46%608.06M57.09%4.33B75.23%3.33B112.25%2.7B182.13%1.5B37.29%2.76B
Operating cost 0.54%290.15M-62.22%1.03B-65.58%744.9M-69.04%542.55M-69.54%288.59M96.02%2.74B151.46%2.16B202.20%1.75B361.11%947.56M60.33%1.4B
Operating tax surcharges 48.62%3.04M-31.63%12.17M-47.30%5.63M-50.56%4.23M-42.78%2.04M77.41%17.8M58.25%10.69M70.24%8.55M34.24%3.57M4.14%10.03M
Operating expense 9.45%159.81M-30.08%649.99M-30.87%465.93M-43.47%315.5M-58.21%146.02M44.28%929.61M24.42%673.97M53.54%558.11M101.00%349.41M2.09%644.31M
Administration expense -8.68%58.49M-0.32%227.13M-23.38%150.73M-29.74%106.24M-12.89%64.05M-14.32%227.85M5.56%196.72M24.46%151.23M16.88%73.53M40.81%265.94M
Financial expense -155.96%-7.25M-817.68%-6.41M60.48%-11.3M-88.51%-13.39M67.60%12.96M-101.43%-697.96K-209.34%-28.59M-132.07%-7.1M85.74%7.73M74.90%48.92M
-Interest expense (Financial expense) -10.42%7.14M-7.99%29.93M-4.81%21.49M-0.04%14.71M6.85%7.98M17.21%32.53M4.79%22.58M3.27%14.71M7.02%7.46M149.21%27.76M
-Interest Income (Financial expense) -108.50%-5.27M-435.67%-27.61M-265.23%-15.19M-121.92%-9.03M-224.51%-2.53M-70.87%-5.15M-150.37%-4.16M-205.02%-4.07M-13.94%-779.41K64.78%-3.02M
Research and development 11.80%105.55M-9.75%378M-16.14%259.47M-19.91%190.74M-20.18%94.4M7.09%418.84M11.85%309.4M31.82%238.15M43.13%118.28M39.96%391.09M
Credit Impairment Loss -368.29%-8.46M92.91%-1.5M92.74%-885.39K85.44%-1.62M97.79%-1.81M4.18%-21.14M8.93%-12.2M10.97%-11.1M-1,027.87%-81.85M-185.22%-22.06M
Asset Impairment Loss ----85.41%-11.52M-------------1,244.43%-78.97M------------94.94%-5.87M
Other net revenue -88.63%962.56K357.37%78.88M13.06%73.72M27.21%45.45M110.99%8.47M-80.23%17.25M-19.05%65.2M-36.55%35.73M-797.67%-77.04M238.49%87.22M
Fair value change income --867.58K15.51%14.8M281.58%14.23M-98.04%289.84K----21.42%12.81M--3.73M--14.81M----4,351.73%10.55M
Invest income 81.08%2.96M-47.97%31.1M-23.74%26.48M83.34%22.22M-39.81%1.63M25.92%59.77M-27.69%34.72M-60.16%12.12M-69.12%2.71M48.60%47.47M
-Including: Investment income associates -669.69%-3M-233.77%-4.33M-2,264.09%-3.06M73.99%-1.08M66.39%-390.3K156.38%3.24M-96.20%141.57K-248.87%-4.14M-194.79%-1.16M188.79%1.26M
Asset deal income ----100.77%80.14K-8,757.56%-55.22K-4,937.69%-55.22K---59.91K-183,304.02%-10.4M-99.68%637.85-99.28%1.14K-----103.12%-5.67K
Other revenue -35.62%5.6M-16.77%45.92M-12.83%33.95M23.68%24.6M315.37%8.7M-3.45%55.17M-14.82%38.95M-47.91%19.89M-77.98%2.1M100.46%57.14M
Operating profit 8.72%252.27M-59.85%549.14M-67.76%462.77M-71.63%388.22M-77.86%232.04M97.68%1.37B108.18%1.44B113.82%1.37B495.71%1.05B-6.51%691.9M
Add:Non operating Income -65.58%228.83K16.58%3.55M126.48%2.12M168.03%1.27M10.43%664.73K8.17%3.04M-6.61%935.96K-41.79%473.82K39.19%601.92K849.12%2.81M
Less:Non operating expense -24.54%897.9K90.81%11.92M-11.85%5.4M0.41%2.89M31.16%1.19M-56.07%6.25M43.14%6.13M4.51%2.88M55.44%907.22K50.41%14.22M
Total profit 8.68%251.6M-60.37%540.76M-67.87%459.49M-71.70%386.6M-77.91%231.51M100.52%1.36B108.42%1.43B114.10%1.37B496.05%1.05B-6.90%680.49M
Less:Income tax cost 6.35%31.16M-69.42%53.33M-68.39%61.8M-71.82%53.77M-79.95%29.3M264.04%174.41M228.27%195.48M138.34%190.8M525.74%146.15M-58.02%47.91M
Net profit 9.02%220.44M-59.04%487.43M-67.79%397.69M-71.68%332.82M-77.57%202.21M88.14%1.19B97.03%1.23B110.62%1.18B491.50%901.71M2.56%632.58M
Net profit from continuing operation 9.02%220.44M-58.74%491.01M-67.79%397.69M-71.68%332.82M-77.57%202.21M83.81%1.19B97.03%1.23B110.62%1.18B491.50%901.71M4.97%647.47M
Net income from discontinuing operating -------3.58M-------------------------------14.88M
Less:Minority Profit 243.94%2.11M97.17%-196.42K60.16%-2.12M41.13%-1.68M18.45%-1.47M-274.78%-6.94M-697.92%-5.33M-227.87%-2.85M39.63%-1.8M89.33%-1.85M
Net profit of parent company owners 7.20%218.33M-59.26%487.62M-67.75%399.81M-71.60%334.5M-77.46%203.68M88.68%1.2B97.67%1.24B111.98%1.18B481.32%903.51M0.04%634.43M
Earning per share
Basic earning per share 6.52%0.49-59.41%1.1-67.62%0.91-71.54%0.76-77.56%0.4689.51%2.7197.89%2.81111.90%2.67485.71%2.05-0.69%1.43
Diluted earning per share 6.52%0.49-59.41%1.1-67.62%0.91-71.54%0.76-77.56%0.4689.51%2.7197.89%2.81111.90%2.67485.71%2.05-0.69%1.43
Other composite income 5.66%413.48K-151.84%-109.99M-79.64%2.22M-57.68%1.91M-80.12%391.33K-223.20%-43.67M2,422.29%10.89M789.91%4.52M264.77%1.97M73.16%35.45M
Other composite income of parent company owners 5.66%413.48K-151.84%-109.99M-79.64%2.22M-57.68%1.91M-80.12%391.33K-223.20%-43.67M2,422.29%10.89M789.91%4.52M264.77%1.97M73.16%35.45M
Total composite income 9.01%220.86M-67.08%377.44M-67.89%399.9M-71.62%334.74M-77.58%202.6M71.62%1.15B98.92%1.25B111.68%1.18B490.70%903.68M4.83%668.03M
Total composite income of parent company owners 7.19%218.75M-67.26%377.64M-67.86%402.03M-71.55%336.42M-77.46%204.07M72.18%1.15B99.56%1.25B113.04%1.18B480.57%905.48M2.33%669.88M
Total composite income of minority owners 243.94%2.11M97.17%-196.42K60.16%-2.12M41.13%-1.68M18.45%-1.47M-274.78%-6.94M-697.92%-5.33M-227.87%-2.85M39.63%-1.8M89.33%-1.85M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg